Jane Street
TERN

Jane Street’s Terns Pharmaceuticals TERN Stock Holding History

Jane Street’s Portfolio TERN Stock Details TERN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-290,100
Closed -$15.3M – 13111
2026
Q1 		$15.3M Sell
290,100
-46,100
-14% -$1.89M ﹤0.01% 2039
2025
Q4 		$13.6M Buy
336,200
+213,700
+174% +$4.94M ﹤0.01% 1964
2025
Q3 		$920K Buy
+122,500
New +$782K ﹤0.01% 6478
2025
Q2 		– Sell
-11,500
Closed -$31.7K – 10871
2025
Q1 		$31.7K Sell
11,500
-14,200
-55% -$58K ﹤0.01% 9082
2024
Q4 		$142K Sell
25,700
-70,300
-73% -$476K ﹤0.01% 8608
2024
Q3 		$801K Buy
96,000
+78,100
+436% +$643K ﹤0.01% 6311
2024
Q2 		$122K Buy
+17,900
New +$108K ﹤0.01% 8655
2024
Q1 		– Sell
-21,900
Closed -$142K – 10067
2023
Q4 		$142K Sell
21,900
-1,400
-6% -$7.4K ﹤0.01% 8422
2023
Q3 		$117K Sell
23,300
-17,600
-43% -$112K ﹤0.01% 7885
2023
Q2 		$358K Buy
+40,900
New +$477K ﹤0.01% 6851

Other funds holding TERN

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Jane Street's TERN Position: Q2 2026 in Review

Jane Street sold out of Terns Pharmaceuticals (TERN) in Q2 2026, closing a stake of 7,231 shares — an estimated $381K sold.

Jane Street first reported a position in TERN in Q2 2021 and held it in 13 quarters. The position peaked at $3.59M in Q4 2025. 1 fund tracked by Wall St. Rank holds TERN as of Q2 2026.

  • Jane Street reported no remaining Terns Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Jane Street sold 7,231 Terns Pharmaceuticals shares in Q2 2026, an estimated $381K.
  • Jane Street first reported a position in Terns Pharmaceuticals in Q2 2021 and held it in 13 quarters.
  • Jane Street's Terns Pharmaceuticals position peaked at $3.59M in Q4 2025.
  • 1 fund tracked by Wall St. Rank held Terns Pharmaceuticals as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.